Following Christopher Castiglia and Christopher Reed’s warning against the gradual disappearance of HIV/AIDS from cultural and political agendas, this essay directs its attention to two Canadian plays that are concerned with the formation of memories at the height of the HIV/AIDS crisis: the late Gordon Armstrong’s Blue Dragons (1993) and Daniel MacIvor’s The Soldier Dreams (1997). Both plays feature dead characters that make unexpected appearances on stage as living ghosts and active participants in the respective plots. What is the dramaturgical effect of these embodied shadow characters, and what are the political implications of these dead queer bodies coming alive on stage? Using the concept of ghosting as a theoretical guideline, the essay analyzes how the strategy of granting the dead person with HIV/AIDS a queer embodied absence on stage marks a dramaturgical and historiographical paradigm shift for queer theatre in Canada.
Contributing to an intercultural understanding of American and European theatre during the postwar era, this essay explores the significance of the Swedish publisher and producer Lars Schmidt for the introduction and spread of US plays and musicals on his side of the Atlantic. Schmidt’s innovative publishing strategies and production methods, in addition to his skills as a cultural translator, made works like The Glass Menagerie , Cat on a Hot Tin Roof , and My Fair Lady commercially viable and intelligible to audiences in various national contexts. In the process, he was largely responsible for the emergence of the individual producer in Europe, a position that was perceived as foreign and, at times, vehemently dismissed as too commercial and too American.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.